 |
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December 2024 (Q4 2024).
Sustained revenue growth
Read more: Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
Hashtag.net.au
Dental emergencies rarely arrive with a polite warning. They burst in like an unexpected storm, bringing pain, discomfort, and urgency. In such moments, having access to a reliable emergency dental ...
Hashtag.net.au
For many Australians living with significant disability, the question of where to live — and how to live there safely and comfortably — is one of the most important and most complex they will ever f...
Hashtag.net.au
If you're running a construction site, a civil project, or a trade-based operation anywhere in Australia, first aid preparedness probably sits somewhere near the bottom of your planning checklist — ...